Abstract
5/2024
vol. 111
Special paper
Basal Cell Carcinoma: Diagnostic and Therapeutic Management – Expert Opinion of the Polish Dermatological Society
- Department of Dermatology, Pediatric and Oncologic Dermatology, Medical University of Lodz, Poland
- Laboratory of Autoinflammatory, Genetic and Rare Skin Disorders, Medical University of Lodz, Poland
- Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Poland
- Department of Dermatology, Medical University of Warsaw, Poland
- Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sk³odowska-Curie Memorial Cancer Centre and Institute of Oncology, Branch in Gliwice, Poland
- Department of Dermatology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Poland
- Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Department of Dermatology, Military Institute of Medicine, Warsaw, Poland
- Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury, Olsztyn, Poland
- Department of Dermatology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
- Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland
- Department of Dermatology in Zabrze, Silesian Medical University in Katowice, Poland
- Department of Dermatology and Venereology, Medical University of Lodz, Poland
- Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sk³odowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland
- Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Poland
- Department of Cosmetology and Aesthetic Dermatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
- Department of Oncological Surgery, Oncology Centre, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
- Sub-Department of Chemotherapy and Department of One-Day Chemotherapy, NU-MED Specialized Oncology Hospital, Tomaszow Mazowiecki, Poland
Dermatol Rev/Przegl Dermatol 2024, 111, 319-333
Online publish date: 2025/02/25
The incidence of skin cancer continues to rise, presenting a significant epidemiological challenge for contemporary medicine. The most prevalent cancer in the Caucasian population is basal cell carcinoma. The gold standard for diagnosing skin cancers remains histopathological examination. However, for low-risk basal cell carcinoma subtypes, non-invasive imaging techniques may suffice to confirm the diagnosis, particularly prior to planned topical or destructive therapies. The guidelines below outline the clinical and pathomorphological subtypes of basal cell carcinoma, its dermoscopic characteristics, staging, and the available options for treatment and prevention of recurrence. The primary and preferred treatment method is the surgical removal of the lesion. The remaining non-surgical methods have lower cure rates and should therefore be reserved for cases with a low risk of recurrence, when surgery is contraindicated or not feasible.
Keywords
basal cell carcinoma, recommendations
Coverage in
Integrated with


